SCHEMBL5355883

SCHEMBL5355883

O=C(Cc1ccc(F)cc1)c1ccc(Cl)cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.57
HIF1A Q16665 2/20 0.57
ALDH1A1 P00352 1/20 0.57
SMN1; SMN2 Q16637 3/20 0.56
LMNA P02545 3/20 0.56
HTT P42858 2/20 0.56
PIK3CA P42336 3/20 0.51
ERCC5 P28715 1/20 0.51
FEN1 P39748 1/20 0.51
MAPT P10636 3/20 0.50
KDM4E B2RXH2 2/20 0.50
ALOX15 P16050 2/20 0.50
FLT1 P17948 1/20 0.50
FLT4 P35916 1/20 0.50
KDR P35968 1/20 0.50
TP53 P04637 1/20 0.50
HSD17B10 Q99714 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
CYP3A4 P08684 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1404500 0.90 MAPK1 (0.65) MAPK1HIF1AALDH1A1SMN1; SMN2PIK3CA
SCHEMBL5364188 0.84 NPC1 (0.61) MAPK1HIF1AALDH1A1SMN1; SMN2LMNA
SCHEMBL2843543 0.84 MAPK1 (0.57) MAPK1HIF1AALDH1A1SMN1; SMN2LMNA
SCHEMBL1250955 0.83 ALDH1A1 (0.61) MAPK1HIF1AALDH1A1SMN1; SMN2LMNA
SCHEMBL3097093 0.81 SMN1; SMN2 (0.49) MAPK1HIF1AALDH1A1SMN1; SMN2LMNA
SCHEMBL5095058 0.81 ALDH1A1 (0.57) MAPK1HIF1AALDH1A1SMN1; SMN2LMNA
SCHEMBL1849729 0.80 RAB9A (0.62) MAPK1HIF1AALDH1A1SMN1; SMN2LMNA
SCHEMBL8956100 0.80 LMNA (0.51) MAPK1HIF1AALDH1A1SMN1; SMN2LMNA
SCHEMBL3584263 0.79 LMNA (0.68) MAPK1HIF1AALDH1A1SMN1; SMN2LMNA
SCHEMBL1848693 0.78 SMN1; SMN2 (0.65) MAPK1ALDH1A1SMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271266-B2 Substituted 2,3-diphenyl pyridines MERCK & CO., INC. (US) 2007-09-18 US disclosed
US-20050182103-A1 Substituted 2,3-diphenyl pyridines MERCK SHARP & DOHME CORP. 2005-08-18 US disclosed
EP-1492784-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES Merck & Co., Inc. (US) 2005-01-05 EP disclosed
WO-2003082191-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES MERCK & CO., INC. (US) 2003-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182103-A1 Substituted 2,3-diphenyl pyridines CNR1, CNR2, MAG MAPK1 631/4885HIF1A 994/4885ALDH1A1 2993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.